AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
Log in

NASDAQ:TRVITrevi Therapeutics Insider Trades

$5.00
-0.49 (-8.93 %)
(As of 07/9/2020 11:14 AM ET)
Add
Compare
Today's Range
$5.00
Now: $5.00
$5.00
50-Day Range
$2.66
MA: $4.71
$7.62
52-Week Range
$1.33
Now: $5.00
$8.49
Volume100 shs
Average Volume83,977 shs
Market Capitalization$89.20 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58

Insider Trades

Trevi Therapeutics (NASDAQ:TRVI) Insider Buying and Selling Activity

Insider Ownership Percentage: 47.30%

Insider Buying and Selling by Quarter


Trevi Therapeutics (NASDAQ TRVI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/3/2020Enterprise Associates 16 NewMajor ShareholderSell564$2.66$1,500.24  
5/9/2019Anne VanlentDirectorBuy5,000$10.00$50,000.00  
5/9/2019Invest A/S LundbeckfondMajor ShareholderBuy375,000$10.00$3,750,000.00  
5/9/2019Jennifer L GoodInsiderBuy11,250$10.00$112,500.00  
(Data available from 1/1/2013 forward)
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.